Telehealth platforms stepping in as TRT primary care: what to know

What did @morgangodvin actually say?

She said it plainly: her methadone clinic has "essentially assumed my primary care." Within 30 minutes of asking, she saw a doctor for an infected hair follicle inside her nostril. The clinic's psychiatrist took over her psych meds, manages her sleep disorder, and handles general medical concerns. Her point was not just personal gratitude. It was a structural critique: methadone, in most of the US system, is always siloed from everything else a patient needs medically. "No one can just have one doctor that deals with everything," she said. That observation is doing more policy work than most healthcare op-eds published this year.

For context, she is cash-pay at this clinic despite having insurance through UCLA, where she works as project director of drug checking LA. The clinic uses a sliding scale. She disclosed her income. None of this is incidental. It tells you exactly who integrated OUD care is actually serving when the system allows it to exist.

Does the science back this up?

Yes, strongly. The evidence for integrated primary care within opioid treatment programs is not thin. It is a well-documented gap with well-documented solutions that the system ignores anyway.

Korthuis et al. (2017, JAMA Internal Medicine) found that integrating primary care into opioid treatment programs significantly improved HIV screening, hepatitis C treatment initiation, and chronic disease management compared to standard referral-based care. Patients in integrated settings were more likely to remain in treatment and more likely to have non-opioid health conditions addressed. A separate Cochrane review (Day et al., 2019) confirmed that co-located care models reduced emergency department utilization among people receiving opioid agonist therapy. The American Society of Addiction Medicine has endorsed integrated care models in its clinical practice guidelines since at least 2020. The barrier is not evidence. It is regulatory structure, funding silos, and frankly, stigma baked into how methadone is federally regulated under the Narcotic Addict Treatment Act of 1974, which still requires dispensing through specialized opioid treatment programs rather than standard primary care offices.

What did they get wrong (or right)?

She got the structural critique exactly right. Credit where it is due: the claim that mandatory counseling minutes are "not evidence-based" is accurate and important.

Federal regulations historically required a minimum of 50 minutes of counseling per month for stable methadone patients. SAMHSA's own 2023 final rule on opioid treatment programs acknowledged the lack of evidence for specific minute thresholds and moved toward more individualized counseling requirements. Research by Schwartz et al. (2012, Journal of Substance Abuse Treatment) found no significant difference in outcomes between patients receiving minimal versus intensive counseling in methadone programs when other support was available. She is not editorializing. She is citing real policy problems that regulators have only partially addressed.

What she did not say, but is worth noting: not every methadone clinic has this level of integrated care. Her experience appears to reflect an unusually well-resourced or mission-driven program. Framing this as a systemic possibility rather than a rare exception is accurate but could be read as more available than it actually is for most patients.

What should you actually know?

The structural problem she describes is real and has a name: care fragmentation for people with opioid use disorder. And it costs lives.

People receiving methadone maintenance treatment have significantly higher rates of hepatitis C, HIV, cardiovascular disease, and mental health comorbidities than the general population (Larney et al., 2015, Drug and Alcohol Dependence). When their OUD care is siloed from primary care, those conditions go unmanaged. Emergency departments pick up the slack at enormous cost and worse outcomes. The integrated model her clinic uses is not experimental. It is evidence-based. It is just not the norm because methadone is still federally regulated in a way that isolates it from the rest of medicine.

Her point about the VA is also worth taking seriously. Veterans with OUD face particular access challenges. A 2021 study in Psychiatric Services found that fewer than half of VA facilities with OUD treatment offered buprenorphine or methadone through integrated primary care pathways. If her VA experience reflects that gap, it is consistent with the literature.

• Mandatory counseling hour requirements for methadone patients are not supported by outcome data for stable patients
• Integrated care models reduce ED use and improve chronic disease management in OUD patients
• Methadone's regulatory isolation from primary care is a policy choice, not a clinical necessity
• Most patients do not have access to the kind of integrated clinic she is describing